Trademark Overview
On Friday, January 30, 2004, a trademark application was filed for BLOODGENIE with the United States Patent and Trademark Office. The USPTO has given the BLOODGENIE trademark a serial number of 78359990. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 5, 2005. This trademark is owned by ChondroGene Limited. The BLOODGENIE trademark is filed in the Medical Instrument Products category with the following description:
optical disc media and other electronic media providing gene expression profile information for use in predicting disease, selecting therapeutics, evaluating the efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for clinical, laboratory, or medical use to diagnose, prognose, predict or evaluate disease; diagnostic devices for selecting therapeutics, evaluating efficacy and toxicity of a therapeutic treatment regime, and evaluating treatment progression; point-of-care equipment for carrying out and/or evaluating medical-diagnostic examinations; optical disc media and other electronic media providing gene expression profile information for use in predicting disease, selecting therapeutics, evaluating the efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for clinical, laboratory, or medical use to diagnose, prognose, predict or evaluate disease; diagnostic devices for selecting therapeutics, evaluating effic...
